aTyr Pharma Inc.

NASDAQ: ATYR · Real-Time Price · USD
4.90
-0.09 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
4.93
0.61%
After-hours: Aug 15, 2025, 07:48 PM EDT

aTyr Pharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-64.02M -50.39M -45.34M -33.77M
Depreciation & Amortization
1.54M 2.74M 1.7M 1.3M
Stock-Based Compensation
2.99M 2.6M 2.15M 1.61M
Other Working Capital
-5.98M 2.7M 4.35M -4.24M
Other Non-Cash Items
-2.71M -3.19M 436K 363K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-6.92M 15.01M -833K -2.59M
Operating Cash Flow
-69.12M -33.22M -41.89M -33.08M
Capital Expenditures
-65K -4.21M -1.64M -192K
Cash Acquisitions
7K n/a 179K 50K
Purchase of Investments
-69.1M -106.98M -42.12M -126.51M
Sales Maturities Of Investments
86.39M 91.05M 90.83M 35.08M
Other Investing Acitivies
n/a 15K n/a n/a
Investing Cash Flow
17.23M -20.13M 47.24M -91.57M
Debt Repayment
-497K -394K -66K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
100K 105K 45K 73K
Financial Cash Flow
39.86M 66.23M 5.45M 110.03M
Net Cash Flow
-12.02M 12.88M 10.81M -14.62M
Free Cash Flow
-69.18M -37.44M -43.53M -33.27M